SCHEMBL4529807

SCHEMBL4529807

Cc1ccc(OC(C(=O)NO)c2ccccc2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
LMNA P02545 5/20 0.50
RORC P51449 2/20 0.47
MAPT P10636 5/20 0.46
KMT2A Q03164 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MEN1 O00255 2/20 0.46
HTR1E P28566 2/20 0.46
S1PR3 Q99500 2/20 0.46
HTT P42858 2/20 0.46
TP53 P04637 1/20 0.46
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MMP8 P22894 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4541579 0.92 ALDH1A1 (0.47) ALDH1A1LMNARORCMAPTKMT2A
SCHEMBL9063161 0.85 ALDH1A1 (0.51) ALDH1A1LMNARORCMAPTKMT2A
SCHEMBL4536114 0.84 PPARG (0.50) ALDH1A1LMNARORCMAPTKMT2A
SCHEMBL4526444 0.83 KMT2A (0.51) ALDH1A1LMNARORCMAPTKMT2A
SCHEMBL4536431 0.78 OPRM1 (0.46) LMNAKMT2AL3MBTL1MEN1HTT
SCHEMBL4536701 0.77 MMP8 (0.48) LMNAKMT2ATP53PPARANPSR1
SCHEMBL4534237 0.75 PPARA (0.47) ALDH1A1LMNAMAPTKMT2AL3MBTL1
SCHEMBL4533785 0.75 KMT2A (0.53) ALDH1A1LMNAMAPTKMT2AL3MBTL1
SCHEMBL4534368 0.75 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AL3MBTL1MMP8
SCHEMBL4537890 0.74 CRHR1 (0.42) ALDH1A1PPARAMMP8HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 532/4885LMNA 424/4885RORC 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.